• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者N端前脑钠肽变化的决定因素及生存预测

Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.

作者信息

Snaedal Sunna, Qureshi Abdul R, Carrero Juan J, Heimbürger Olof, Stenvinkel Peter, Bárány Peter

机构信息

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Blood Purif. 2014;37(2):138-45. doi: 10.1159/000360267. Epub 2014 Apr 8.

DOI:10.1159/000360267
PMID:24732340
Abstract

BACKGROUND/AIMS: N-Terminal pro-brain natriuretic peptide (NT-proBNP) is a predictor of cardiac events and death in the general population and in chronic kidney disease. There is limited information on how natriuretic peptides vary in dialysis patients. The aim of this study was to analyze NT-proBNP variability, factors predicting its variability and survival related to NT-proBNP variability.

METHODS

A prospective 3-month observational study of prevalent hemodialysis patients with monthly measurements of NT-proBNP was carried out. A total of 211 hemodialysis patients were included, and mortality was recorded during 52 months of follow-up.

RESULTS

Inflammation was the strongest predictor of NT-proBNP variability. Patients with constantly high NT-proBNP had an increased risk of death adjusting for age, sex, dialysis vintage and comorbidity but not when also adjusting for nutritional status.

CONCLUSIONS

Longitudinal changes in NT-proBNP are associated with changes in inflammation, nutritional status, age and comorbidity. Due to strong interactions with predictors of mortality such as nutritional status, we were unable to confirm NT-proBNP as an independent marker for mortality in dialysis patients.

摘要

背景/目的:N末端脑钠肽前体(NT-proBNP)是普通人群和慢性肾脏病患者心脏事件及死亡的预测指标。关于利钠肽在透析患者中的变化情况,相关信息有限。本研究旨在分析NT-proBNP的变异性、预测其变异性的因素以及与NT-proBNP变异性相关的生存率。

方法

对现患血液透析患者进行为期3个月的前瞻性观察研究,每月测量NT-proBNP。共纳入211例血液透析患者,并在52个月的随访期间记录死亡率。

结果

炎症是NT-proBNP变异性的最强预测因素。NT-proBNP持续处于高水平的患者,在调整年龄、性别、透析龄和合并症后死亡风险增加,但在同时调整营养状况后则不然。

结论

NT-proBNP的纵向变化与炎症、营养状况、年龄和合并症的变化相关。由于与营养状况等死亡率预测因素存在强烈相互作用,我们无法确认NT-proBNP为透析患者死亡率的独立标志物。

相似文献

1
Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.血液透析患者N端前脑钠肽变化的决定因素及生存预测
Blood Purif. 2014;37(2):138-45. doi: 10.1159/000360267. Epub 2014 Apr 8.
2
Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.与高敏肌钙蛋白T相比,NTproBNP在透析患者中具有更高的预测价值:一项前瞻性观察性试点研究。
Kidney Blood Press Res. 2014;39(6):636-47. doi: 10.1159/000368452. Epub 2014 Dec 19.
3
NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.NT-proBNP、液体容量超负荷和透析方式是 ESRD 患者死亡的独立预测因素。
Nephrol Dial Transplant. 2010 Feb;25(2):551-7. doi: 10.1093/ndt/gfp395. Epub 2009 Aug 12.
4
N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.稳定透析患者N末端B型利钠肽原的变异性
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):620-9. doi: 10.2215/CJN.09060914. Epub 2015 Feb 24.
5
N-terminal-pro-B-type-natriuretic peptide associated with 2-year mortality from both cardiovascular and non-cardiovascular origins in prevalent chronic hemodialysis patients.在现患慢性血液透析患者中,N-末端 pro-B 型利钠肽与心血管和非心血管来源的 2 年死亡率相关。
Ren Fail. 2018 Nov;40(1):127-134. doi: 10.1080/0886022X.2018.1437047.
6
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.N末端B型利钠肽原(NT-proBNP)对慢性肾脏病5期血液透析患者左心室功能障碍的诊断价值
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
7
N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.N末端前脑钠肽可独立预测蛋白质能量消耗,并与维持性血液透析患者的全因死亡率相关。
Am J Nephrol. 2009;29(6):516-23. doi: 10.1159/000185628. Epub 2008 Dec 12.
8
Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?三种利钠肽在血液透析患者中的诊断性能比较:哪种是合适的生物标志物?
Kidney Blood Press Res. 2012;36(1):172-81. doi: 10.1159/000343406. Epub 2012 Oct 30.
9
Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.慢性血液透析患者中的脑钠肽和N末端前脑钠肽原
Nephron Clin Pract. 2006;103(4):c162-72. doi: 10.1159/000092914. Epub 2006 Apr 25.
10
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.比较中段心房利钠肽原与N末端B型利钠肽原在预测慢性心力衰竭患者生存率中的作用
J Am Coll Cardiol. 2007 Nov 13;50(20):1973-80. doi: 10.1016/j.jacc.2007.08.012. Epub 2007 Oct 29.

引用本文的文献

1
N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis.血液透析患者的N端前B型利钠肽与营养不良
Int J Nephrol. 2020 Mar 5;2020:9528014. doi: 10.1155/2020/9528014. eCollection 2020.
2
N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.N端前B型利钠肽作为维持性血液透析患者肌肉量减少的生物标志物
PLoS One. 2016 Nov 21;11(11):e0166804. doi: 10.1371/journal.pone.0166804. eCollection 2016.
3
Vasoactive Peptide Levels after Change of Dialysis Mode.
透析模式改变后的血管活性肽水平
Nephron Extra. 2015 Oct 28;5(3):67-78. doi: 10.1159/000440816. eCollection 2015 Sep-Dec.